Cue Biopharma, Inc. (CUE) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -10.94M | -1.08M | -9.02M | -3.42M | -8.17M | -9.03M | -7.53M | -9.99M | -9.78M | -10.96M | -7.8M | -10.37M | -10.83M | -10.51M | -6.87M | -12.85M | -11.57M | -10.65M | -6.63M | -9.77M |
| Operating CF Margin % | -192.44% | -4.9% | -419.92% | -115.61% | -1941.09% | -572.84% | -225.63% | -375.85% | -569.83% | -601.76% | -371.38% | -750.43% | -5793.05% | -6962.88% | -10104.41% | -49415.38% | -1157.3% | -128.96% | -276.7% | -356.7% |
| Operating CF Growth % | -33.9% | 88.08% | -19.89% | 65.82% | 16.48% | 17.61% | 3.49% | 3.67% | 9.68% | -4.22% | -13.51% | 19.28% | 6.39% | 1.23% | -3.68% | -31.5% | 1.88% | -52.09% | 13.79% | -42.34% |
| Net Income | -5.18M | 1.58M | -7.45M | -8.48M | -12.26M | -9.5M | -8.66M | -10.17M | -12.35M | -13.43M | -11.01M | -13.19M | -13.11M | -14.59M | -10.96M | -13.21M | -14.26M | -8.38M | -12.99M | -10.28M |
| Depreciation & Amortization | 566K | 1.46M | 79K | 796K | 882K | -238K | 877K | 862K | 849K | 851K | 856K | 849K | 880K | 580.05K | 539K | 458K | 229K | -2.73M | 316K | 2.57M |
| Stock-Based Compensation | 48K | 610K | 0 | 1.26M | 1.34M | 1.56M | 1.58M | 1.75M | 1.95M | 2.07M | 2.07M | 2.04M | 2M | 2.11M | 2.06M | 2.31M | 3.01M | 2.97M | 0 | 2.85M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.04M | 0 | 0 |
| Other Non-Cash Items | 353K | -262K | 1.96M | 42K | 41K | 45K | -55K | 42K | 42K | 200K | 31K | -32K | -109K | -195.78K | -59K | -202K | 3K | -6.44M | 4.4M | -1.14M |
| Working Capital Changes | -6.73M | -4.47M | -3.62M | 2.97M | 1.82M | -901K | -1.27M | -2.48M | -274K | -647K | 246K | -40K | -493K | 1.58M | 1.54M | -2.21M | -561K | 895.54K | 1.65M | -3.77M |
| Change in Receivables | 195K | -5.16M | 145K | -2.43M | 945K | 2.21M | -1.3M | -447K | 298K | -38K | -526K | -938K | -139K | 738.27K | -60K | 189K | 2.22M | -2.37M | 1.13M | -491K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.77M | 0 | 0 |
| Change in Payables | -622K | 1.6M | -1.28M | -157K | 961K | -3.65M | 2.57M | -13K | 418K | 1.02M | 124K | 205K | -580K | 629.11K | 477K | -1.05M | 26K | 120.4K | -522K | 719K |
| Cash from Investing | -121K | 7.02M | -6.77M | -27K | -150K | -1K | 98K | -10K | -55K | 0 | 5M | 5M | 15M | 5M | -29.52M | -62K | -27K | 511 | -11K | -233K |
| Capital Expenditures | -121K | 0 | 0 | -27K | -150K | -2K | 1K | -10K | -55K | 0 | 0 | 0 | 0 | -746 | -78K | -65K | -27K | -39 | -13K | -252K |
| CapEx % of Revenue | 2.13% | - | - | 0.91% | 35.63% | 0.13% | 0.03% | 0.38% | 3.2% | - | - | - | - | 0.49% | 114.71% | 250% | 2.7% | 0% | 0.54% | 9.2% |
| Acquisitions | 0 | 20K | 20K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 205 | 3K | 0 | 0 | 10M | 2K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 30K | 0 | 0 | 0 | 1K | 97K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 0 | 131 | 0 | 19K |
| Cash from Financing | 306K | 9.49M | 1K | 17.8M | -1M | -932K | 9.82M | -1M | 2.35M | 4.78M | 4.59M | 2.1M | 388K | 27.4M | -9K | 11.11M | 15.16M | 7.38M | 351K | 10.67M |
| Debt Issued (Net) | 0 | -1.5M | -1M | -1M | -1M | -999K | -1M | -1M | -1M | -1M | -1M | 0 | 0 | 251 | 0 | 0 | 10M | 0 | 0 | 0 |
| Equity Issued (Net) | 306K | 10.99M | 1M | 18.8M | 0 | 49K | 10.82M | 0 | 3.35M | 5.78M | 5.59M | 2.02M | 388K | 27.4M | -9K | 11.11M | 5.49M | 7.03M | 351K | 10.36M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 127 | -9K | 0 | 0 | 0 | -482K | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 18K | 0 | 0 | 0 | 0 | 0 | 85K | 0 | 0 | 0 | 0 | -333K | 354.65K | 0 | 309K |
| Net Change in Cash | -10.76M | 15.44M | -15.79M | 14.36M | -9.32M | -9.96M | 2.39M | -11M | -7.49M | -6.18M | 1.79M | -3.27M | 4.71M | 21.89M | -36.4M | -1.8M | 3.56M | -3.26M | -6.29M | 663K |
| Free Cash Flow | -11.06M | -1.08M | -9.02M | -3.44M | -8.32M | -9.03M | -7.53M | -10M | -9.84M | -10.96M | -7.8M | -10.37M | -10.83M | -10.51M | -6.95M | -12.91M | -11.6M | -10.65M | -6.64M | -10.02M |
| FCF Margin % | -194.57% | -4.9% | -419.92% | -116.52% | -1976.72% | -572.97% | -225.6% | -376.22% | -573.03% | -601.76% | -371.38% | -750.43% | -5793.05% | -6963.38% | -10219.12% | -49665.38% | -1160% | -128.96% | -277.24% | -365.9% |
| FCF Growth % | -32.94% | 88.08% | -19.9% | 65.58% | 15.42% | 17.59% | 3.5% | 3.58% | 9.18% | -4.22% | -12.23% | 19.69% | 6.61% | 1.23% | -4.65% | -28.85% | 6.77% | -49.78% | 17.34% | -43.07% |
| FCF per Share | -2.30 | -0.29 | -2.68 | -1.08 | -3.36 | -3.65 | -4.41 | -5.98 | -5.97 | -6.97 | -5.05 | -6.95 | -7.28 | -8.05 | -5.89 | -10.96 | -10.66 | -10.13 | -6.36 | -9.63 |
| FCF Conversion (FCF/Net Income) | 2.11x | -0.68x | 1.21x | 0.40x | 0.67x | 0.95x | 0.87x | 0.98x | 0.79x | 0.82x | 0.71x | 0.79x | 0.83x | 0.72x | 0.63x | 0.97x | 0.81x | 1.27x | 0.51x | 0.95x |
| Interest Paid | 0 | 0 | 0 | 67K | 90K | 122K | 155K | 183K | 209K | 235K | 262K | 176K | 0 | 0 | 0 | 193K | 21K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |